Emmanuel S Antonarakis

Emmanuel S Antonarakis

UNVERIFIED PROFILE

Are you Emmanuel S Antonarakis?   Register this Author

Register author
Emmanuel S Antonarakis

Emmanuel S Antonarakis

Publications by authors named "Emmanuel S Antonarakis"

Are you Emmanuel S Antonarakis?   Register this Author

100Publications

1529Reads

17Profile Views

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.

Prostate 2020 Apr 23;80(5):407-411. Epub 2020 Jan 23.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23955DOI Listing
April 2020

Does sequencing order of antiandrogens in prostate cancer matter?

Nat Rev Urol 2020 Apr;17(4):197-198

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-020-0289-9DOI Listing
April 2020

A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.

Prostate Cancer Prostatic Dis 2020 Mar 14;23(1):184-193. Epub 2019 Oct 14.

Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-019-0176-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031012PMC
March 2020

Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations.

Prostate Cancer Prostatic Dis 2020 Mar 5. Epub 2020 Mar 5.

Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-020-0217-3DOI Listing
March 2020

Therapeutic targeting of the DNA damage response in prostate cancer.

Curr Opin Oncol 2020 Mar 9. Epub 2020 Mar 9.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000617DOI Listing
March 2020

Germline BLM mutations and metastatic prostate cancer.

Prostate 2020 Feb 5;80(2):235-237. Epub 2019 Nov 5.

Tulane Cancer Center, New Orleans, Louisiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009322PMC
February 2020

Androgen receptor variant-driven prostate cancer II: advances in clinical investigation.

Prostate Cancer Prostatic Dis 2020 Feb 24. Epub 2020 Feb 24.

Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Divisions of Medical Oncology and Urology, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-020-0215-5DOI Listing
February 2020

Emerging treatments for metastatic castration-resistant prostate cancer: Immunotherapy, PARP inhibitors, and PSMA-targeted approaches.

Cancer Treat Res Commun 2020 Jan 7;23:100164. Epub 2020 Jan 7.

CHM, ESA - The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 201 N. Broadway, Skip Viragh Building, Baltimore, MD 21287, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100164DOI Listing
January 2020

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

World J Urol 2019 Dec 6;37(12):2623-2629. Epub 2018 Sep 6.

Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1550 Orleans Street, CRB2 Rm 406, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2477-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401357PMC
December 2019

Pan-Cancer Analysis of Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype.

Oncologist 2019 12 10;24(12):1526-1533. Epub 2019 Jul 10.

Johns Hopkins University School of Medicine and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975947PMC
December 2019

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.

Int J Radiat Oncol Biol Phys 2019 12 13;105(5):948-956. Epub 2019 Aug 13.

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.08.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050213PMC
December 2019

Hormonal Therapy or Chemotherapy for Metastatic Prostate Cancer - Playing the Right CARD.

N Engl J Med 2019 12;381(26):2564-2566

From Johns Hopkins University, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1912750DOI Listing
December 2019

Circulating tumor cell-based or tissue biopsy-based AR-V7 detection: which provides the greatest clinical utility?

Ann Transl Med 2019 Dec;7(Suppl 8):S354

Departments of Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2019.09.92DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976453PMC
December 2019

Clinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data.

J Med Econ 2019 Oct 28;22(10):1080-1087. Epub 2019 Aug 28.

Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2019.1649267DOI Listing
October 2019

Targeting lineage plasticity in prostate cancer.

Lancet Oncol 2019 Oct 9;20(10):1338-1340. Epub 2019 Sep 9.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30497-8DOI Listing
October 2019

Clinical Significance of AR-V567es in Prostate Cancer-Response.

Clin Cancer Res 2019 Oct;25(19):6010-6011

Weill Cornell Medicine/Meyer Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1820DOI Listing
October 2019

Darolutamide For Castration-Resistant Prostate Cancer.

Onco Targets Ther 2019 23;12:8769-8777. Epub 2019 Oct 23.

Departments of Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S197244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816030PMC
October 2019

Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype.

Prostate 2019 09 7;79(13):1572-1579. Epub 2019 Aug 7.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23881DOI Listing
September 2019

Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.

Eur Urol 2019 Aug 4;76(2):170-176. Epub 2018 Oct 4.

Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA; Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183072
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.09.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447475PMC
August 2019

Reply to L. Dirix, B. De Laere et al, and A. Sharp et al.

J Clin Oncol 2019 Aug 2;37(24):2184-2186. Epub 2019 Jul 2.

Andrew J. Armstrong, MD, ScM and Susan Halabi, PhD, Duke University, Durham, NC; Jun Luo, PhD, Johns Hopkins University, Baltimore, MD; David M. Nanus, MD, Weill Cornell Medical College, New York, NY; Howard I. Scher, MD, Memorial Sloan Kettering Cancer Center, New York, NY; Emmanuel S. Antonarakis, MD, Johns Hopkins University, Baltimore, MD; and Daniel J. George, MD, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01230DOI Listing
August 2019

Clinical implications of mismatch repair deficiency in prostate cancer.

Future Oncol 2019 Jul 25;15(20):2395-2411. Epub 2019 Jun 25.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714067PMC
July 2019

Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale.

Transl Androl Urol 2019 Jul;8(Suppl 3):S341-S345

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2019.05.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642951PMC
July 2019

NCCN Guidelines Updates: Management of Prostate Cancer.

J Natl Compr Canc Netw 2019 May;17(5.5):583-586

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.5011DOI Listing
May 2019

CDK12 inactivation across solid tumors: an actionable genetic subtype.

Oncoscience 2019 May 10;6(5-6):312-316. Epub 2019 May 10.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncoscience.481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650168PMC
May 2019

A New Molecular Taxonomy to Predict Immune Checkpoint Inhibitor Sensitivity in Prostate Cancer.

Oncologist 2019 04 9;24(4):430-432. Epub 2019 Jan 9.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0819DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459249PMC
April 2019

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.

Eur Urol 2019 03 15;75(3):378-382. Epub 2018 Oct 15.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183075
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377812PMC
March 2019

Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?

Ann Transl Med 2019 Mar;7(Suppl 1):S7

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2019.01.37DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462610PMC
March 2019

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.

Eur Urol 2019 01 16;75(1):88-99. Epub 2018 Apr 16.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Department of Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.03.028DOI Listing
January 2019

PARP inhibition - not all gene mutations are created equal.

Nat Rev Urol 2019 01;16(1):4-6

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-018-0129-3DOI Listing
January 2019

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies.

Prostate Cancer Prostatic Dis 2018 11 9;21(4):539-548. Epub 2018 Jul 9.

Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-018-0061-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283851PMC
November 2018

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer.

Oncotarget 2018 Nov 9;9(88):35797-35798. Epub 2018 Nov 9.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254684PMC
November 2018

Targeting ELK1: a wELKome addition to the prostate cancer armamentarium.

AME Med J 2018 Oct 31;3. Epub 2018 Oct 31.

Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/amj.2018.10.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287613PMC
October 2018

The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation.

Prostate Cancer Prostatic Dis 2018 09 20;21(3):306-318. Epub 2017 Dec 20.

Duke University Medical Center and Cancer Institute, Duke Prostate and Urologic Cancer Center, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-017-0014-9DOI Listing
September 2018

Detection of AR-V7 transcript with RNA in situ hybridization in human salivary duct cancer.

Oral Oncol 2018 09 28;84:134-136. Epub 2018 Jun 28.

Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2018.06.026DOI Listing
September 2018

Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer.

N Engl J Med 2018 09;379(11):1087-1089

From the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcibr1808772DOI Listing
September 2018

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?

Precis Cancer Med 2018 Sep 18;1. Epub 2018 Sep 18.

Departments of Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://pcm.amegroups.com/article/view/4509/5530
Publisher Site
http://dx.doi.org/10.21037/pcm.2018.09.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201248PMC
September 2018

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.

Eur Urol 2018 08 10;74(2):218-225. Epub 2018 Feb 10.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.01.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045965PMC
August 2018

Reply to C. Ren et al.

J Clin Oncol 2018 08 12;36(22):2356-2357. Epub 2018 Jun 12.

Emmanuel S. Antonarakis, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.2680
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.2680DOI Listing
August 2018

Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?

Lancet Oncol 2018 07 4;19(7):860-861. Epub 2018 Jun 4.

Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30409-1DOI Listing
July 2018

p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer.

Prostate Cancer Prostatic Dis 2018 06 4;21(2):260-268. Epub 2018 Jan 4.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41391-017-0027-4
Publisher Site
http://dx.doi.org/10.1038/s41391-017-0027-4DOI Listing
June 2018

Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer.

Am J Pathol 2018 06 22;188(6):1478-1485. Epub 2018 Mar 22.

Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, Maryland; Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029440173117
Publisher Site
http://dx.doi.org/10.1016/j.ajpath.2018.02.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971230PMC
June 2018

PARP inhibitors for homologous recombination-deficient prostate cancer.

Expert Opin Emerg Drugs 2018 06 4;23(2):123-133. Epub 2018 Apr 4.

a Oncology and Urology , Johns Hopkins Sidney Kimmel Cancer Center , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2018.1459563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088797PMC
June 2018

PD-1/PD-L1 pathway inhibitors in advanced prostate cancer.

Expert Rev Clin Pharmacol 2018 May 24;11(5):475-486. Epub 2018 Apr 24.

a Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins University , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2018.1464388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317331PMC
May 2018

Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions.

Future Oncol 2018 Apr 20;14(10):907-917. Epub 2017 Dec 20.

Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2017-0531
Publisher Site
http://dx.doi.org/10.2217/fon-2017-0531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925432PMC
April 2018

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.

J Clin Oncol 2018 04 20;36(10):991-999. Epub 2017 Dec 20.

Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University; Walter M. Stadler, University of Chicago, Chicago; Daniel H. Shevrin, NorthShore University Health System, Evanston, IL; Maha Hussain, Stephanie Daignault-Newton, Lakshmi P. Kunju, Javed Siddiqui, Yi-Mi Wu, Dan Robinson, Robert J. Lonigro, Xuhong Cao, Scott A. Tomlins, Rohit Mehra, David C. Smith, Megan V. Caram, and Arul M. Chinnaiyan, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Przemyslaw W. Twardowski, City of Hope Cancer Center, Duarte; Felix Y. Feng, University of California San Francisco, San Francisco, CA; Costantine Albany, Simon Cancer Center, Indiana University, Indianapolis, IN; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Kathleen A. Cooney, University of Utah, Salt Lake City, UT; Bruce Montgomery, University of Washington, Seattle, WA; Emmanuel S. Antonarakis, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Paul G. Corn, University of Texas MD Anderson Cancer Center, Houston, TX; Young E. Whang, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; and Karen E. Knudsen, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.7310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075827PMC
April 2018

Germline genetic testing in prostate cancer - further enrichment in variant histologies?

Oncoscience 2018 Mar 29;5(3-4):62-64. Epub 2018 Apr 29.

Departments of Oncology and Urology, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncoscience.403DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978447PMC
March 2018

Circulating Tumor Cell Eradication as an Intermediate Efficacy End Point for Metastatic Castration-Resistant Prostate Cancer: Is There Enough Evidence?

J Clin Oncol 2018 02 22;36(6):525-527. Epub 2017 Dec 22.

Emmanuel S. Antonarakis, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5487DOI Listing
February 2018

CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer.

Expert Rev Mol Diagn 2018 02 16;18(2):155-163. Epub 2018 Jan 16.

b Departments of Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center , Johns Hopkins University School of Medicine , Baltimore , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2018.1427068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088794PMC
February 2018

AR Signaling in Human Malignancies: Prostate Cancer and Beyond.

Cancers (Basel) 2018 Jan 18;10(1). Epub 2018 Jan 18.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB1-1M45, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/10/1/22
Publisher Site
http://dx.doi.org/10.3390/cancers10010022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789372PMC
January 2018

BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations.

Expert Opin Investig Drugs 2017 Dec 27;26(12):1391-1397. Epub 2017 Oct 27.

a Department of Oncology , Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1393518DOI Listing
December 2017

Surrogate end points in early prostate cancer clinical states: ready for implementation?

Ann Transl Med 2017 Dec;5(24):502

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2017.10.25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750273PMC
December 2017

Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.

Prostate Cancer 2017 21;2017:8560827. Epub 2017 Nov 21.

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/8560827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735648PMC
November 2017

Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancer.

Clin Adv Hematol Oncol 2017 Oct;15(10):785-795

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
October 2017

Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications.

Ther Adv Med Oncol 2017 Aug 5;9(8):565-573. Epub 2017 Jul 5.

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, CRB1-1M45, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834017719215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524249PMC
August 2017

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

BMC Cancer 2017 Jun 29;17(1):453. Epub 2017 Jun 29.

Department of Radiation Oncology & Molecular Radiation Sciences, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1550 Orleans Street, CRB2 Rm 406, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3455-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492934PMC
June 2017